Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FZMY7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,332
Award facts
- Contract value 100% obligated
- $8,331.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Nexplanon 68 mg implants. The contract, valued at $8,331.72 with an ultimate completion date of August 26, 2025, carries no set-aside designation. Nexplanon is a subdermal contraceptive implant used by military and federal healthcare facilities to support reproductive health services across the Department of Defense healthcare system.
This delivery order was issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and valid through November 2026. The IDC enables the agency to procure a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables to support military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, demonstrating consistent capability in delivering specialized pharmaceutical products to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FZMY7?
SPE2DB25FZMY7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FZMY7 worth?
The government has obligated $8,332 on SPE2DB25FZMY7.
Is contract SPE2DB25FZMY7 an order under another contract?
Yes. SPE2DB25FZMY7 is a delivery order under SPE2DB24D9210, an indefinite delivery contract.
Was contract SPE2DB25FZMY7 competed?
The extent of competition for SPE2DB25FZMY7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award